Skip to main content
HR 4278 117th Congress House Health

To direct the Comptroller General of the United States to conduct a study on how direct-to-consumer pharmaceutical advertising negatively impacts drug costs to consumers, and for other purposes.

Introduced: June 30, 2021 Introduced by: Murphy, Gregory F. Republican · North Carolina See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 1, 2021
Referred to the Subcommittee on Health.
Jun 30, 2021
Referred to the House Committee on Energy and Commerce.
Jun 30, 2021
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

This bill requires the Government Accountability Office to study and report on how direct-to-consumer pharmaceutical advertising negatively impacts drug costs to consumers.

What's happening now July 1, 2021

Referred to the Subcommittee on Health.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 1
All 1 Republican 1
R
Harshbarger, Diana
Tennessee · Jun 30, 2021
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 4278: To direct the Comptroller General of the United States to conduct a study on how direct-to-consumer pharmaceutical advertising negatively impacts drug costs to consumers, and for other purposes.. 117th Congress. Open America. https://openamerica.io/bill/117-HR-4278/
MLA
"H.R. 4278: To direct the Comptroller General of the United States to conduct a study on how direct-to-consumer pharmaceutical advertising negatively impacts drug costs to consumers, and for other purposes.." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-4278/.
Bluebook (legal)
H.R. 4278, 117th Cong. (2026), https://openamerica.io/bill/117-HR-4278/.
Markdown link
[H.R. 4278: To direct the Comptroller General of the United States to conduct a study on how direct-to-consumer pharmaceutical advertising negatively impacts drug costs to consumers, and for other purposes.](https://openamerica.io/bill/117-HR-4278/)
Report a problem